ILMN Illumina Inc

Price (delayed)

$406.65

Market cap

$59.37B

P/E Ratio

93.7

Dividend/share

N/A

EPS

$4.34

Enterprise value

$59.46B

Sector: Healthcare
Industry: Diagnostics & Research

Illumina, Inc. is an American company. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a ...

Highlights

The equity has increased by 6% YoY and by 3% from the previous quarter
The quick ratio has contracted by 43% YoY but it has grown by 3.7% from the previous quarter
The stock's price to earnings (P/E) is 77% more than its 5-year quarterly average of 53.0 and 59% more than its last 4 quarters average of 59.1
ILMN's net income is down by 34% year-on-year and by 8% since the previous quarter

Key stats

What are the main financial stats of ILMN
Market
Shares outstanding
146M
Market cap
$59.37B
Enterprise value
$59.46B
Valuations
Price to earnings (P/E)
93.7
Price to book (P/B)
12.63
Price to sales (P/S)
18.34
EV/EBIT
68.27
EV/EBITDA
56.47
EV/Sales
18.36
Earnings
Revenue
$3.24B
EBIT
$871M
EBITDA
$1.05B
Free cash flow
$933M
Per share
EPS
$4.34
Free cash flow per share
$6.39
Book value per share
$32.19
Revenue per share
$22.18
TBVPS
$43.55
Balance sheet
Total assets
$7.4B
Total liabilities
$2.7B
Debt
$1.85B
Equity
$4.7B
Working capital
$3.21B
Liquidity
Debt to equity
0.39
Current ratio
3.88
Quick ratio
3.4
Net debt/EBITDA
0.09
Margins
EBITDA margin
32.5%
Gross margin
69%
Net margin
19.7%
Operating margin
22.1%
Efficiency
Return on assets
8.7%
Return on equity
13.8%
Return on invested capital
16.5%
Return on capital employed
13.8%
Return on sales
26.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ILMN stock price

How has the Illumina stock price performed over time
Intraday
0.44%
1 week
8.05%
1 month
9.62%
1 year
22.85%
YTD
9.91%
QTD
9.91%

Financial performance

How have Illumina's revenue and profit performed over time
Revenue
$3.24B
Gross profit
$2.24B
Operating income
$715M
Net income
$638M
Gross margin
69%
Net margin
19.7%
ILMN's net income is down by 34% year-on-year and by 8% since the previous quarter
Illumina's net margin has decreased by 30% YoY and by 4.8% QoQ
The operating income has decreased by 22% YoY and by 17% from the previous quarter
Illumina's operating margin has decreased by 16% YoY and by 14% from the previous quarter

Growth

What is Illumina's growth rate over time

Valuation

What is Illumina stock price valuation
P/E
93.7
P/B
12.63
P/S
18.34
EV/EBIT
68.27
EV/EBITDA
56.47
EV/Sales
18.36
The stock's price to earnings (P/E) is 77% more than its 5-year quarterly average of 53.0 and 59% more than its last 4 quarters average of 59.1
Illumina's EPS has decreased by 34% YoY and by 8% QoQ
The price to book (P/B) is 26% higher than the last 4 quarters average of 10.0 and 15% higher than the 5-year quarterly average of 11.0
The equity has increased by 6% YoY and by 3% from the previous quarter
ILMN's P/S is 49% above its 5-year quarterly average of 12.3 and 35% above its last 4 quarters average of 13.6
Illumina's revenue has decreased by 6% YoY and by 3.4% QoQ

Efficiency

How efficient is Illumina business performance
The ROE has contracted by 42% YoY and by 9% from the previous quarter
The company's return on assets fell by 36% YoY and by 9% QoQ
ILMN's return on invested capital is down by 24% year-on-year and by 5% since the previous quarter
Illumina's return on sales has decreased by 19% YoY and by 2.5% QoQ

Dividends

What is ILMN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ILMN.

Financial health

How did Illumina financials performed over time
The total assets is 174% more than the total liabilities
The quick ratio has contracted by 43% YoY but it has grown by 3.7% from the previous quarter
The current ratio has contracted by 43% YoY but it has grown by 3.2% from the previous quarter
Illumina's debt is 61% lower than its equity
The equity has increased by 6% YoY and by 3% from the previous quarter
The debt to equity is down by 4.9% year-on-year and by 2.5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.